Seeking Alpha

Doc 224899 » Comments » AVGN

  • Treating Parkinson’s Disease - Investment Opportunities and Challenges [View article]
    We are at the threshold of seeing marketable clinical applications for all the clinical pharmocogenomics research that has gone on for the past 20 years. Parkinson's Disease is an excellent illness to target, from both a scientific point of view and from a financial point of view.

    But, you can bet your BDNF that you will not see any useful new treatments developed and available before YOU are disabled by Parkinson's if Obama-Care Reform is passed. Why do I say that? Because if you look at the proposed flow chart for getting an aspirin from your doctor, you can imagine what the product research and development flow chart would look like!
    Aug 03 12:28 pm |Rating: 0 0 |Link to Comment
More on AVGN by Doc 224899
Comments by Ticker
AAUKY.PK, ABAT, ABGOF.PK, ABT, ABX, ACE, ACI, ACXIF.PK, ADS, AEG, AEM, AET, AFK, AGIGF.PK, AIG, ALU, AMED, AMGN, AMLN, AMN, AONE, APC, APOG, APWR, ASA, ASO, ATHN, AU, AUY, AVARF.PK, AVGN, AXA, AXP, AXPW.OB, AZ, AZK, AZN, BA, BAC, BC, BCS, BFR, BHI, BHP, BIEL.PK, BJ, BMY, BP, BRE, BRK.A,
Doc 224899's
Comments Stats
268 comments
Rating: 494 (773 - 279 )